Author

Alexander Christopher Jonathan Van Akkooi

Institution: The Netherlands Cancer Institute

Observed institution: The Netherlands Cancer Institute

OpenAlex ID: A5104124503

Multicenter phase 2 study to identify the optimal neo-adjuvant combination scheme of ipilimumab (IPI) and nivolumab (NIVO) (OpACIN-neo).

2017 · Elisa A. Rozeman, Alexander Christopher Jonathan Van Akkooi, et al. · Journal of Clinical Oncology · 4

Works count: 1

Citation count: 4

H-index: 1

I10-index: